Suzannah J Harnor
Suzannah J Harnor
Northern Institute for Cancer Research
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Cyclin-dependent kinase (CDK) inhibitors: structure–activity relationships and insights into the CDK-2 selectivity of 6-substituted 2-arylaminopurines
CR Coxon, E Anscombe, SJ Harnor, MP Martin, B Carbain, BT Golding, ...
Journal of medicinal chemistry 60 (5), 1746-1767, 2017
492017
Targeting DNA‐dependent protein kinase for cancer therapy
SJ Harnor, A Brennan, C Cano
ChemMedChem 12 (12), 895-900, 2017
342017
The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18 F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice
EJ Haagensen, HD Thomas, I Wilson, SJ Harnor, SL Payne, T Rennison, ...
PLoS One 8 (12), e81763, 2013
152013
Human toxicity caused by indole and indazole carboxylate synthetic cannabinoid receptor agonists: from horizon scanning to notification
SL Hill, M Dunn, C Cano, SJ Harnor, IR Hardcastle, J Grundlingh, ...
Clinical chemistry 64 (2), 346-354, 2018
102018
Photochemical synthesis of benz[h]isoquinolines
BM Abbott, FD Ferrari, SJ Harnor, JC Barnes, R Marquez
Tetrahedron 64 (22), 5072-5078, 2008
82008
Structure-activity analysis of CJ-15,801 analogues that interact with Plasmodium falciparum pantothenate kinase and inhibit parasite proliferation
C Spry, AL Sewell, Y Hering, MVJ Villa, J Weber, SJ Hobson, SJ Harnor, ...
European Journal of Medicinal Chemistry 143, 1139-1147, 2018
52018
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4
SM Myers, DC Miller, L Molyneux, M Arasta, RH Bawn, TJ Blackburn, ...
European journal of medicinal chemistry 178, 530-543, 2019
42019
Concise syntheses of bridged morpholines
AV Zaytsev, JE Pickles, SJ Harnor, AP Henderson, M Alyasiri, PG Waddell, ...
RSC advances 6 (59), 53955-53957, 2016
32016
Synthesis of 3′-deoxy-3′-fluorothymidine (FLT) 5′-O-glucuronide: a reference standard for imaging studies with [18 F] FLT
SJ Harnor, T Rennison, M Galler, C Cano, RJ Griffin, DR Newell, ...
MedChemComm 5 (7), 984-988, 2014
32014
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase
CJ Matheson, CR Coxon, R Bayliss, K Boxall, B Carbain, AM Fry, ...
RSC Medicinal Chemistry, 2020
12020
Inhibition of the DNA-Dependent Protein Kinase for Cancer Therapy
SJ Harnor, A Brennan, C Cano
Med Chem (Los Angeles) 7, 172-177, 2017
12017
Chronic Glucokinase Activator treatment activates liver Carbohydrate Response Element binding protein and improves hepatocyte ATP homeostasis during substrate challenge
BE Ford, SS Chachra, A Alshawi, A Brennan, S Harnor, C Cano, DJ Baker, ...
Diabetes, Obesity and Metabolism, 2020
2020
Approach in Oncology
C Cano, SJ Harnor, E Willmore, SR Wedge
Targeting the DNA Damage Response for Anti-Cancer Therapy, 2018
2018
Targeting DNA-PK as a Therapeutic Approach in Oncology
C Cano, SJ Harnor, E Willmore, SR Wedge
Targeting the DNA Damage Response for Anti-Cancer Therapy, 339-357, 2018
2018
Modulation of the DNA-Damage Response by Inhibitors of the Phosphatidylinositol 3-Kinase Related Kinase (PIKK) Family
S Harnor, J Pickles, C Cano
Cancer II, 189-189, 2017
2017
Design and synthesis of dual inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions
S Adhikari, C Cano, B Golding, I Hardcastle, S Harnor, C Jennings, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
2015
Synthesis and biological evaluation of potential isoform-selective benzimidazole-4-carboxamide inhibitors of poly (ADP-ribose) polymerases
J Pickles, C Cano, B Golding, S Harnor, S Jackson, H Newell, J Travers, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 249, 2015
2015
Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
S Tudhope, Y Zhao, A Wittner, E Wilmore, A Bertoli, S Adhikari, SJ Harnor, ...
Cancer Research 74 (19 Supplement), 5451-5451, 2014
2014
Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction
A Bertoli, S Adhikari, SJ Harnor, Y Zhao, J Lunec, SR Wedge, S Tudhope, ...
247th ACS National Meeting and Exposition, 2014
2014
The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor
EJ Haagensen, HD Thomas, I Wilson, SJ Harnor, SL Payne
2013
The system can't perform the operation now. Try again later.
Articles 1–20